216 related articles for article (PubMed ID: 32222072)
21. Vogt-Koyanagi-Harada disease.
Joye A; Suhler E
Curr Opin Ophthalmol; 2021 Nov; 32(6):574-582. PubMed ID: 34545845
[TBL] [Abstract][Full Text] [Related]
22. Genetic association of PRKCD and CARD9 polymorphisms with Vogt-Koyanagi-Harada disease in the Chinese Han population.
Zhou C; Cai S; Xie Y; Zeng Z; Zhang J; Su G; Wu Q; Ye X; Cao Q; Yang P; Hu J
Hum Genomics; 2023 Feb; 17(1):9. PubMed ID: 36782298
[TBL] [Abstract][Full Text] [Related]
23. Vogt-koyanagi-harada syndrome.
Fang W; Yang P
Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
[TBL] [Abstract][Full Text] [Related]
24. HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.
Iqniebi A; Gaafar A; Sheereen A; Al-Suliman A; Mohamed G; Al-Hussein K; Tabbara KF
Mol Vis; 2009 Sep; 15():1876-80. PubMed ID: 19756183
[TBL] [Abstract][Full Text] [Related]
25. [The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].
Xiao T; Jiang Y; You X
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):268-71. PubMed ID: 10451958
[TBL] [Abstract][Full Text] [Related]
26. Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2D
Bonacini M; Cimino L; De Simone L; Bolletta E; Gozzi F; Soriano A; Muratore F; Zerbini A; Fontana L; Salvarani C; Croci S
Clin Exp Immunol; 2021 Apr; 204(1):41-48. PubMed ID: 33314028
[TBL] [Abstract][Full Text] [Related]
27. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
28. Humoral immune response directed against LEDGF in patients with VKH.
Yamada K; Senju S; Shinohara T; Nakatsura T; Murata Y; Ishihara M; Nakamura S; Ohno S; Negi A; Nishimura Y
Immunol Lett; 2001 Oct; 78(3):161-8. PubMed ID: 11578690
[TBL] [Abstract][Full Text] [Related]
29. TLR3 and TLR4 But not TLR2 are Involved in Vogt-Koyanagi- Harada Disease by Triggering Proinflammatory Cytokines Production Through Promoting the Production of Mitochondrial Reactive Oxygen Species.
Liang L; Tan X; Zhou Q; Tian Y; Kijlstra A; Yang P
Curr Mol Med; 2015; 15(6):529-42. PubMed ID: 26238371
[TBL] [Abstract][Full Text] [Related]
30. A de novo missense mutation in MPP2 confers an increased risk of Vogt-Koyanagi-Harada disease as shown by trio-based whole-exome sequencing.
Liu X; Meng J; Liao X; Liu Y; Zhou Q; Xu Z; Yin S; Cao Q; Su G; He S; Li W; Wang X; Wang G; Li D; Yang P; Hou S
Cell Mol Immunol; 2023 Nov; 20(11):1379-1392. PubMed ID: 37828081
[TBL] [Abstract][Full Text] [Related]
31. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
[TBL] [Abstract][Full Text] [Related]
32. Vogt-Koyanagi-Harada disease in pediatric, adult and elderly: clinical characteristics and visual outcomes.
Yang P; Liao W; Pu Y; Zhong Z; Wang H; Yu Q; Cai J; Wang W; Su G
Graefes Arch Clin Exp Ophthalmol; 2023 Sep; 261(9):2641-2650. PubMed ID: 37058172
[TBL] [Abstract][Full Text] [Related]
33. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
34. Characteristics, Upon Presentation, of a Cohort of Patients with Vogt-Koyanagi-Harada Disease in Puerto Rico.
Barquet V; Rodríguez E; Fantauzzi A; Ortíz JC; Ulloa-Padilla JP; Vilá-Delgado MS; Fernández CJ; Almodóvar JC; Santos C; Oliver AL
P R Health Sci J; 2021 Nov; 40(4):168-173. PubMed ID: 35077075
[TBL] [Abstract][Full Text] [Related]
35. Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease.
Yang J; Hu J; Feng L; Yi S; Ye Z; Lin M; Liu X; Pu Y; Kijlstra A; Yang P; Li H
Ocul Immunol Inflamm; 2020; 28(2):200-208. PubMed ID: 30794473
[No Abstract] [Full Text] [Related]
36. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
Xu M; Wang C; Tian Y; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2014 Aug; 22(4):294-9. PubMed ID: 24329541
[TBL] [Abstract][Full Text] [Related]
37. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
[TBL] [Abstract][Full Text] [Related]
38. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
39. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
40. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
Liu L; Yang P; He H; Lin X; Jiang L; Chi W; Zhao C; Zhou H
Br J Ophthalmol; 2008 Apr; 92(4):557-61. PubMed ID: 18245271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
